These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

537 related articles for article (PubMed ID: 4305197)

  • 1. An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine.
    Kapikian AZ; Mitchell RH; Chanock RM; Shvedoff RA; Stewart CE
    Am J Epidemiol; 1969 Apr; 89(4):405-21. PubMed ID: 4305197
    [No Abstract]   [Full Text] [Related]  

  • 2. Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine.
    Kim HW; Canchola JG; Brandt CD; Pyles G; Chanock RM; Jensen K; Parrott RH
    Am J Epidemiol; 1969 Apr; 89(4):422-34. PubMed ID: 4305198
    [No Abstract]   [Full Text] [Related]  

  • 3. Respiratory syncytial virus in infants and children.
    Parrott RH; Kim HW; Brandt CD; Chanock RM
    Prev Med; 1974 Dec; 3(4):473-80. PubMed ID: 4373702
    [No Abstract]   [Full Text] [Related]  

  • 4. Respiratory virus immunization. I. A field trial of two inactivated respiratory virus vaccines; an aqueous trivalent parainfluenza virus vaccine and an alum-precipitated respiratory syncytial virus vaccine.
    Fulginiti VA; Eller JJ; Sieber OF; Joyner JW; Minamitani M; Meiklejohn G
    Am J Epidemiol; 1969 Apr; 89(4):435-48. PubMed ID: 4305199
    [No Abstract]   [Full Text] [Related]  

  • 5. Epidemiology of respiratory syncytial virus infection in Washington, D.C. I. Importance of the virus in different respiratory tract disease syndromes and temporal distribution of infection.
    Kim HW; Arrobio JO; Brandt CD; Jeffries BC; Pyles G; Reid JL; Chanock RM; Parrott RH
    Am J Epidemiol; 1973 Sep; 98(3):216-25. PubMed ID: 4355005
    [No Abstract]   [Full Text] [Related]  

  • 6. Epidemiology of respiratory syncytial virus infection in Washington, D.C. 3. Composite analysis of eleven consecutive yearly epidemics.
    Brandt CD; Kim HW; Arrobio JO; Jeffries BC; Wood SC; Chanock RM; Parrott RH
    Am J Epidemiol; 1973 Nov; 98(5):355-64. PubMed ID: 4355632
    [No Abstract]   [Full Text] [Related]  

  • 7. Field evaluation of a respiratory syncytial virus vaccine and a trivalent parainfluenza virus vaccine in a pediatric population.
    Chin J; Magoffin RL; Shearer LA; Schieble JH; Lennette EH
    Am J Epidemiol; 1969 Apr; 89(4):449-63. PubMed ID: 4305200
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical and immunological response of infants and children to administration of low-temperature adapted respiratory syncytial virus.
    Kim HW; Arrobio JO; Pyles G; Brandt CD; Camargo E; Chanock RM; Parrott RH
    Pediatrics; 1971 Nov; 48(5):745-55. PubMed ID: 4330595
    [No Abstract]   [Full Text] [Related]  

  • 9. Antibodies to respiratory syncytial virus in a normal community in Chandigarh area, northern India.
    Agarwal SC; Mahajan RC; Bardoloi JN; Ganguly NK
    Bull World Health Organ; 1971; 45(2):143-5. PubMed ID: 4333697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Tecumseh study of respiratory illness. 3. Incidence and periodicity of respiratory syncytial virus and Mycoplasma pneumoniae infections.
    Monto AS; Lim SK
    Am J Epidemiol; 1971 Sep; 94(3):290-301. PubMed ID: 4328570
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunity to infections of the respiratory system in man and animals.
    Jacobs JW
    Dev Biol Stand; 1975; 28():609-16. PubMed ID: 165132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and antigenicity of temperature sensitive (TS) mutant respiratory syncytial virus (RSV) in infants and children.
    Kim HW; Arrobio JO; Brandt CD; Wright P; Hodes D; Chanock RM; Parrott RH
    Pediatrics; 1973 Jul; 52(1):56-63. PubMed ID: 4353352
    [No Abstract]   [Full Text] [Related]  

  • 13. Repeated infections with respiratory syncytial virus.
    Beem M
    J Immunol; 1967 Jun; 98(6):1115-22. PubMed ID: 4290804
    [No Abstract]   [Full Text] [Related]  

  • 14. Potential of attenuated respiratory syncytial virus vaccine for infants and children.
    Parrott RH; Kim HW; Brandt CD; Chanock RM
    Dev Biol Stand; 1975; 28():389-99. PubMed ID: 165119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Respiratory syncytial virus associated with acute respiratory infections in Trinidadian patients.
    Spence L; Barratt N
    Am J Epidemiol; 1968 Sep; 88(2):257-66. PubMed ID: 4299816
    [No Abstract]   [Full Text] [Related]  

  • 16. The Tecumseh study of respiratory illness. VII. Further observations on the occurrence of respiratory syncytial virus and Mycoplasma pneumoniae infections.
    Monto AS; Bryan ER; Rhodes LM
    Am J Epidemiol; 1974 Dec; 100(6):458-68. PubMed ID: 4374887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The respiratory syncytial (RS) virus and the infections caused by it].
    De Rosa F; Pauluzzi S
    Recenti Prog Med; 1971 Feb; 50(2):91-115. PubMed ID: 4329318
    [No Abstract]   [Full Text] [Related]  

  • 18. Differentiation of actively and passively acquired complement-fixing antibodies in infants with respiratory syncytial virus infection.
    Jacobs JW; Peacock DB
    J Med Microbiol; 1970 May; 3(2):313-24. PubMed ID: 4318079
    [No Abstract]   [Full Text] [Related]  

  • 19. Epidemiology of respiratory syncytial virus infection among infants and children in Chicago.
    Mufson MA; Levine HD; Wasil RE; Mocega-Gonzalez HE; Krause HE
    Am J Epidemiol; 1973 Aug; 98(2):88-95. PubMed ID: 4353439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Report of a workshop: disease accentuation after immunization with inactivated microbial vaccines.
    Craighead JE
    J Infect Dis; 1975 Jun; 131(6):749-54. PubMed ID: 1169271
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 27.